Product information and disease descriptionPlace of product in therapyDisease description
Long-term morbidity
6 evidence topics · 7 sources
Colectomy: 10% to 20% of patients require proctocolectomy for refractory disease
“Although the therapeutic options are expanding, 10-20% of patients still require proctocolectomy for medically refractory disease.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The 5- and 10-year cumulative risk of colectomy is 10–15%; achieving mucosal healing is associated with lower risk of colectomy.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Disease extent consistently influences risk of colectomy (OR 2.2; 95% CI, 1.1–4.3), with significantly higher risk in patients with extensive colitis (10y cumulative risk, 19%), followed by left-sided colitis (8%) and ulcerative proctitis (5%) (16,18,20).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Colorectal cancer: risk by disease duration and extent
“The risk of colorectal cancer after 20 years of disease duration is 4.5%, and people with UC have a 1.7-fold higher risk for colorectal cancer compared with the general population.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Cumulative probability of CRC at 10, 20, and 30 years after UC diagnosis was 0.4–0.6%, 1.1–5.4%, and 2.1–7.5%, respectively (43,44). This risk is increased in patients with pancolitis (SIR, 2.4–14.8) and left-sided colitis (SIR, 1.4–2.8), but not in patients with proctitis (41,45–47). Young age at diagnosis, male sex, extensive colitis, disease duration and concomitant primary sclerosing cholangitis have been consistently identified as risk factors of CRC.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Colorectal cancer: Danish and Swedish cohort of 96,447 patients, 1969 to 2017
“During follow-up, we observed 1336 incident CRCs in the UC cohort (1·29 per 1000 person-years) and 9544 incident CRCs in reference individuals (0·82 per 1000 person-years; HR 1·66, 95% CI 1·57-1·76). In the UC cohort, 639 patients died from CRC (0·55 per 1000 person-years), compared with 4451 reference individuals (0·38 per 1000 person-years; HR 1·59, 95% CI 1·46-1·72) during the same time period.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The excess risks declined over calendar periods: during the last 5 years of follow-up (2013-17, Sweden only), the HR for incident CRC in people with UC was 1·38 (95% CI 1·20-1·60, or one additional case per 1058 patients with UC per 5 years) and the HR for death from CRC was 1·25 (95% CI 1·03-1·51, or one additional case per 3041 patients with UC per 5 years).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Extraintestinal manifestations: joint, ocular, or skin manifestations in 27% of patients
“Fifty-two studies were included that reported on 352 454 patients. The prevalence of at least 1 joint, ocular, or skin extraintestinal manifestation in all IBD, UC, and CD was 24%, 27%, and 35% respectively.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Overall risk of EIMs in patients with UC ranges from 7–17%, probably lower as compared to patients with CD, and approximately 1% patients may present with EIMs before UC diagnosis (13,16,64). Articular manifestations are the most frequently observed EIMs (8%), including peripheral arthritis (5.5%), and ankylosing spondylitis (1%), followed by cutaneous EIMs (1.3%), PSC (0.6%) and ocular manifestations (0.6%) (64,65).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The cumulative incidence of spondyloarthropathy was 5%, 14%, and 22% at 10, 20 and 30y after UC diagnosis (66)” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Serious infections, venous thromboembolism, and cardiovascular events: contemporary US inception cohort
“Cumulative 1- and 5y risk of serious infections in patients with UC was 5.3% (95% CI, 4.6–6.0) and 10.2% (95% CI, 9.1–11.4), respectively.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Cumulative 1- and 5y risks of VTE were 0.1% (95% CI, 0.0–0.1) and 0.3% (95% CI, 0.1–0.5), and of MACE, was 0.2% (95% CI, 0.1–0.3) and 0.9% (95% CI, 0.5–1.3), respectively.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Disability: work disability 1.8 times that of the general population
“Patients with UC had 1.8 times higher risk of work disability (95% CI, 1.4–2.3) as compared to general population, and was comparable to that seen in patients with CD (56).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“While UC is not associated with an increased risk of mortality, it is associated with high morbidity and work disability.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote